Skip to main content
Top
Published in: European Child & Adolescent Psychiatry 8/2014

01-08-2014 | Editorial

Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatment

Authors: Pieter J. Hoekstra, Andrea Dietrich

Published in: European Child & Adolescent Psychiatry | Issue 8/2014

Login to get access

Excerpt

This issue of European Child and Adolescent Psychiatry contains an article that addresses functional impairments associated with subthreshold attention-deficit/hyperactivity disorder (ADHD) [2]. In a Korean nationwide community sample of 921 children, aged 8–11 years, the authors report that children with subthreshold ADHD were found to experience significant functional impairments, i.e., poorer behavioral and emotional control and worse academic performance compared to control children. Subthreshold ADHD was defined by the presence of at least three but no more than five inattentive or hyperactive/impulsive symptoms. However, whereas the diagnostic threshold (≥6/9) for the DSM-IV symptoms represents a clear-cut operationalization for a diagnosis of ADHD, this disregards the fact that for the affected individuals and their parents the relevance of each symptom is likely to be different; for the diagnostic assessment as defined by the DSM-IV the symptoms are merely being counted, without taking the severity of each symptom into account. Furthermore, the subjective and objective impairment due to ADHD symptoms can in theory be greater in a child who fulfills only five symptoms in comparison to a child with six or more symptoms. These considerations illustrate how difficult it is to meaningfully operationalize thresholds for a spectrum disorder such as ADHD. …
Literature
1.
go back to reference Advokat C (2010) What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci Biobehav Rev 34(8):1256–1266PubMedCrossRef Advokat C (2010) What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci Biobehav Rev 34(8):1256–1266PubMedCrossRef
2.
go back to reference Hong SB, Dwyer D, Kim JW, Park EJ, Shin MS, Kim BN, Yoo HJ, Cho IH, Bhang SY, Hong YC, Pantelis C, Cho SC Subthreshold attention-deficit/hyperactivity disorder is associated with functional impairments across domains: a comprehensive analysis in a large-scale community study. Eur Child Adolesc Psychiatry (this issue) Hong SB, Dwyer D, Kim JW, Park EJ, Shin MS, Kim BN, Yoo HJ, Cho IH, Bhang SY, Hong YC, Pantelis C, Cho SC Subthreshold attention-deficit/hyperactivity disorder is associated with functional impairments across domains: a comprehensive analysis in a large-scale community study. Eur Child Adolesc Psychiatry (this issue)
3.
go back to reference van de Loo-Neus GH, Rommelse N, Buitelaar JK (2011) To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol 21(8):584–599PubMedCrossRef van de Loo-Neus GH, Rommelse N, Buitelaar JK (2011) To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol 21(8):584–599PubMedCrossRef
4.
go back to reference McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong IC (2009) Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194(3):273–277PubMedCrossRef McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong IC (2009) Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194(3):273–277PubMedCrossRef
5.
go back to reference Mikirova NA, Rogers AM, Taylor PR, Hunninghake RE, Miranda-Massari JR, Gonzalez MJ (2013) Metabolic correction for attention deficit/hyperactivity disorder: a biochemical–physiological therapeutic approach. Funct Foods Health Dis 3(1):1–20 Mikirova NA, Rogers AM, Taylor PR, Hunninghake RE, Miranda-Massari JR, Gonzalez MJ (2013) Metabolic correction for attention deficit/hyperactivity disorder: a biochemical–physiological therapeutic approach. Funct Foods Health Dis 3(1):1–20
6.
go back to reference Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K (2009) Houck PR; MTA Cooperative Group. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48(5):484–500PubMedCentralPubMedCrossRef Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K (2009) Houck PR; MTA Cooperative Group. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48(5):484–500PubMedCentralPubMedCrossRef
7.
go back to reference Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K (2013) How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. Eur Child Adolesc Psychiatry 22(4):203–216PubMedCrossRef Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K (2013) How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. Eur Child Adolesc Psychiatry 22(4):203–216PubMedCrossRef
8.
go back to reference Rommelse N, Buitelaar J (2013) Is there a future for restricted elimination diets in ADHD clinical practice? Eur Child Adolesc Psychiatry 22:199–202PubMedCrossRef Rommelse N, Buitelaar J (2013) Is there a future for restricted elimination diets in ADHD clinical practice? Eur Child Adolesc Psychiatry 22:199–202PubMedCrossRef
9.
go back to reference Rucklidge JJ, Kaplan BJ (2013) Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother 13(1):49–73PubMedCrossRef Rucklidge JJ, Kaplan BJ (2013) Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother 13(1):49–73PubMedCrossRef
10.
go back to reference Rucklidge JJ, Frampton CM, Gorman B, Boggis A (2014) Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 204:306–315PubMedCrossRef Rucklidge JJ, Frampton CM, Gorman B, Boggis A (2014) Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 204:306–315PubMedCrossRef
11.
go back to reference Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, Simonoff E, Wong IC, Sonuga-Barke E (2014) Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder—an appraisal of the evidence on efficacy and recommendations on the design of future studies. J Child Psychol Psychiatry 55(5):416–427PubMedCrossRef Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, Simonoff E, Wong IC, Sonuga-Barke E (2014) Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder—an appraisal of the evidence on efficacy and recommendations on the design of future studies. J Child Psychol Psychiatry 55(5):416–427PubMedCrossRef
12.
go back to reference Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B (2008) Wigal T; MTA Cooperative Group. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord 12(1):4–14PubMedCrossRef Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B (2008) Wigal T; MTA Cooperative Group. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord 12(1):4–14PubMedCrossRef
Metadata
Title
Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatment
Authors
Pieter J. Hoekstra
Andrea Dietrich
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
European Child & Adolescent Psychiatry / Issue 8/2014
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-014-0594-z

Other articles of this Issue 8/2014

European Child & Adolescent Psychiatry 8/2014 Go to the issue